Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 2Other hematologic neoplasm 1NET 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Breast Neoplasms 2043Triple Negative Breast Neoplasms 207Neoplasm Metastasis 132Neoplasms 119Carcinoma, Non-Small-Cell Lung 95Breast Neoplasms, Male 95Ovarian Neoplasms 87Colorectal Neoplasms 69Lung Neoplasms 66Carcinoma, Intraductal, Noninfiltrating 63Melanoma 56Prostatic Neoplasms 54Pancreatic Neoplasms 47Breast Carcinoma In Situ 42Stomach Neoplasms 38Colonic Neoplasms 37Brain Neoplasms 36Carcinoma, Renal Cell 34Inflammatory Breast Neoplasms 33Head and Neck Neoplasms 32Urinary Bladder Neoplasms 29Pain 29Squamous Cell Carcinoma of Head and Neck 26Small Cell Lung Carcinoma 26Endometrial Neoplasms 25Sarcoma 23Fatigue 23Uterine Cervical Neoplasms 21Esophageal Neoplasms 21Multiple Myeloma 18

Interventions

Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pathologic Processes × Breast × Clear all
NCT01166763 2016-07-18

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

University of Kansas Medical Center

Phase NA Completed
30 enrolled 10 charts
Breast

Breast Diseases, Breast Neoplasms, Hyperplasia, Neoplasms, Neoplasms by Site, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡